These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 34514027)

  • 1. Clinical and Demographic Characteristics of Pyruvate Kinase Deficiency Patients: A Comprehensive Case Series Analysis.
    Nasiri A; Haroon A; Alzahrani H
    Cureus; 2024 May; 16(5):e60035. PubMed ID: 38736761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug product attributes predict clinical efficacy in betibeglogene autotemcel gene therapy for β-thalassemia.
    Whitney D; Shestopalov I; Fincker M; d'Anjou M; Kral K; Gayron M; Pierciey FJ; Colvin RA
    Mol Ther Methods Clin Dev; 2023 Dec; 31():101155. PubMed ID: 38074412
    [No Abstract]   [Full Text] [Related]  

  • 3. Delivery of AAV-based gene therapy through haemophilia centres-A need for re-evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHC.
    Miesbach W; Chowdary P; Coppens M; Hart DP; Jimenez-Yuste V; Klamroth R; Makris M; Noone D; Peyvandi F
    Haemophilia; 2021 Nov; 27(6):967-973. PubMed ID: 34553460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus vector-attributed hepatotoxicity blocks clinical application in gene therapy.
    Wang Z; Zhang X
    Cytotherapy; 2021 Dec; 23(12):1045-1052. PubMed ID: 34548241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentivirus-mediated gene therapy corrects ribosomal biogenesis and shows promise for Diamond Blackfan anemia.
    Giménez Y; Palacios M; Sánchez-Domínguez R; Zorbas C; Peral J; Puzik A; Ugalde L; Alberquilla O; Villanueva M; Río P; Gálvez E; Da Costa L; Strullu M; Catala A; Ruiz-Llobet A; Segovia JC; Sevilla J; Strahm B; Niemeyer CM; Beléndez C; Leblanc T; Lafontaine DL; Bueren J; Navarro S
    JCI Insight; 2024 May; 9(10):. PubMed ID: 38775150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific correction of pyruvate kinase deficiency-causing point mutations by CRISPR/Cas9 and single-stranded oligodeoxynucleotides.
    Fañanas-Baquero S; Morín M; Fernández S; Ojeda-Perez I; Dessy-Rodriguez M; Giurgiu M; Bueren JA; Moreno-Pelayo MA; Segovia JC; Quintana-Bustamante O
    Front Genome Ed; 2023; 5():1104666. PubMed ID: 37188156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative.
    Luque J; Mendes I; Gómez B; Morte B; López de Heredia M; Herreras E; Corrochano V; Bueren J; Gallano P; Artuch R; Fillat C; Pérez-Jurado LA; Montoliu L; Carracedo Á; Millán JM; Webb SM; Palau F; ; Lapunzina P
    Clin Genet; 2022 May; 101(5-6):481-493. PubMed ID: 35060122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyruvate Kinase Deficiency: Current Challenges and Future Prospects.
    Fattizzo B; Cavallaro F; Marcello APML; Vercellati C; Barcellini W
    J Blood Med; 2022; 13():461-471. PubMed ID: 36072510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.
    Bianchi P; Fermo E; Glader B; Kanno H; Agarwal A; Barcellini W; Eber S; Hoyer JD; Kuter DJ; Maia TM; Mañu-Pereira MDM; Kalfa TA; Pissard S; Segovia JC; van Beers E; Gallagher PG; Rees DC; van Wijk R;
    Am J Hematol; 2019 Jan; 94(1):149-161. PubMed ID: 30358897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment.
    Navarro S; Quintana-Bustamante O; Sanchez-Dominguez R; Lopez-Manzaneda S; Ojeda-Perez I; Garcia-Torralba A; Alberquilla O; Law K; Beard BC; Bastone A; Rothe M; Villanueva M; Ramirez JC; Fañanas-Baquero S; Nieto-Romero V; Molinos-Vicente A; Gutierrez S; Nicoletti E; García-Bravo M; Bueren JA; Schwartz JD; Segovia JC
    Mol Ther Methods Clin Dev; 2021 Sep; 22():350-359. PubMed ID: 34514027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safe and Efficient Gene Therapy for Pyruvate Kinase Deficiency.
    Garcia-Gomez M; Calabria A; Garcia-Bravo M; Benedicenti F; Kosinski P; López-Manzaneda S; Hill C; Del Mar Mañu-Pereira M; Martín MA; Orman I; Vives-Corrons JL; Kung C; Schambach A; Jin S; Bueren JA; Montini E; Navarro S; Segovia JC
    Mol Ther; 2016 Aug; 24(7):1187-98. PubMed ID: 27138040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically relevant gene editing in hematopoietic stem cells for the treatment of pyruvate kinase deficiency.
    Fañanas-Baquero S; Quintana-Bustamante O; Dever DP; Alberquilla O; Sanchez-Dominguez R; Camarena J; Ojeda-Perez I; Dessy-Rodriguez M; Turk R; Schubert MS; Lattanzi A; Xu L; Lopez-Lorenzo JL; Bianchi P; Bueren JA; Behlke MA; Porteus M; Segovia JC
    Mol Ther Methods Clin Dev; 2021 Sep; 22():237-248. PubMed ID: 34485608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue of pyruvate kinase deficiency in mice by gene therapy using the human isoenzyme.
    Meza NW; Alonso-Ferrero ME; Navarro S; Quintana-Bustamante O; Valeri A; Garcia-Gomez M; Bueren JA; Bautista JM; Segovia JC
    Mol Ther; 2009 Dec; 17(12):2000-9. PubMed ID: 19755962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells.
    Garate Z; Quintana-Bustamante O; Crane AM; Olivier E; Poirot L; Galetto R; Kosinski P; Hill C; Kung C; Agirre X; Orman I; Cerrato L; Alberquilla O; Rodriguez-Fornes F; Fusaki N; Garcia-Sanchez F; Maia TM; Ribeiro ML; Sevilla J; Prosper F; Jin S; Mountford J; Guenechea G; Gouble A; Bueren JA; Davis BR; Segovia JC
    Stem Cell Reports; 2015 Dec; 5(6):1053-1066. PubMed ID: 26549847
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.